Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Prostate Cancer

  Free Subscription


15.03.2010

2 Am J Clin Oncol
1 Br J Cancer
2 Cancer Lett
5 Cancer Res
1 Clin Cancer Res
2 Int J Cancer
6 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 Mod Pathol
2 Nat Rev Urol
1 Oncol Rep
2 Prostate
1 Semin Radiat Oncol
9 Urol Int
4 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. COHEN KH , Teh BS, Paulino AC, Butler EB, et al
    Ureteral stenosis after postprostatectomy intensity-modulated radiotherapy.
    Am J Clin Oncol. 2010;33:108.
    PubMed     Text format     Related articles   

  2. LIPTON A , Campbell-Baird C, Harvey H, Kim C, et al
    Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases.
    Am J Clin Oncol. 2010;33:75-8.
    PubMed     Text format     Related articles    Abstract available


    Br J Cancer

  3. KOUMAKPAYI IH , Le Page C, Mes-Masson AM, Saad DF, et al
    Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


    Cancer Lett

  4. LIU H , Chen A, Guo F, Yuan L, et al
    A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available

  5. ZHANG Y , Gong LH, Zhang HQ, Du Q, et al
    Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression.
    Cancer Lett. 2010.
    PubMed     Text format     Related articles    Abstract available


    Cancer Res

  6. THIRUKKUMARAN CM , Nodwell MJ, Hirasawa K, Shi ZQ, et al
    Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available

  7. BEN SAHRA I , Laurent K, Giuliano S, Larbret F, et al
    Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available

  8. THOMSEN MK , Ambroisine L, Wynn S, Cheah KS, et al
    SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.
    Cancer Res. 2010;70:979-87.
    PubMed     Text format     Related articles    Abstract available

  9. EDGAR KA , Wallin JJ, Berry M, Lee LB, et al
    Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors.
    Cancer Res. 2010;70:1164-72.
    PubMed     Text format     Related articles    Abstract available

  10. HOLTERMAN CE , Franovic A, Payette J, Lee S, et al
    ETS-1 oncogenic activity mediated by transforming growth factor alpha.
    Cancer Res. 2010;70:730-40.
    PubMed     Text format     Related articles    Abstract available


    Clin Cancer Res

  11. GALLAGHER DJ , Gaudet MM, Pal P, Kirchhoff T, et al
    Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer.
    Clin Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available


    Int J Cancer

  12. LI Q , Kuriyama S, Kakizaki M, Yan H, et al
    History of cholelithiasis and the risk of prostate cancer: The ohsaki cohort study.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available

  13. CATTARUZZA L , Fregona D, Mongiat M, Ronconi L, et al
    Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available


    Int J Radiat Oncol Biol Phys

  14. NGUYEN PL , Chen RC, Hoffman KE, Trofimov A, et al
    Rectal Dose-Volume Histogram Parameters Are Associated with Long-Term Patient-Reported Gastrointestinal Quality of Life After Conventional and High-Dose Radiation for Prostate Cancer: A Subgroup Analysis of a Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2010.
    PubMed     Text format     Related articles    Abstract available

  15. THOMS J , Bristow R, Warde P, Supiot S, et al
    Response to "Intraoperative Radiotherapy During Radical Prostatectomy for Locally Advanced Prostate Cancer: Technical and Dosimetric Aspects" (Int J Radiat Oncol Biol Phys 2009; in press).
    Int J Radiat Oncol Biol Phys. 2010;76:1277.
    PubMed     Text format     Related articles   

  16. FROEHNER M , Koch R, Litz RJ, Wirth MP, et al
    Response to "Predictors of Prostate Cancer-Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy" (Int J Radiat Oncol Biol Phys 2009, in press).
    Int J Radiat Oncol Biol Phys. 2010;76:1274.
    PubMed     Text format     Related articles   

  17. VISWANATHAN AN , Yorke ED, Marks LB, Eifel PJ, et al
    Radiation dose-volume effects of the urinary bladder.
    Int J Radiat Oncol Biol Phys. 2010;76.
    PubMed     Text format     Related articles    Abstract available

  18. HASAN Y , Schoenherr D, Martinez AA, Wilson GD, et al
    Prostate-specific natural health products (dietary supplements) radiosensitize normal prostate cells.
    Int J Radiat Oncol Biol Phys. 2010;76:896-904.
    PubMed     Text format     Related articles    Abstract available

  19. GULLIFORD SL , Foo K, Morgan RC, Aird EG, et al
    Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.
    Int J Radiat Oncol Biol Phys. 2010;76:747-54.
    PubMed     Text format     Related articles    Abstract available


    Int J Urol

  20. NARIMOTO K , Mizokami A, Izumi K, Mihara S, et al
    Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen.
    Int J Urol. 2010.
    PubMed     Text format     Related articles    Abstract available


    Mod Pathol

  21. DE MUGA S , Hernandez S, Agell L, Salido M, et al
    Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas.
    Mod Pathol. 2010.
    PubMed     Text format     Related articles    Abstract available


    Nat Rev Urol

  22. ROACH M
    Prostate cancer: Worse sexual function after cryoablation-a case for EBRT?
    Nat Rev Urol. 2010;7:122-4.
    PubMed     Text format     Related articles   

  23. CHAMIE K , Litwin MS
    Prostate cancer: The challenge of comparing open and laparoscopic surgery.
    Nat Rev Urol. 2010;7:121-2.
    PubMed     Text format     Related articles   


    Oncol Rep

  24. CALLEN DF , Ricciardelli C, Butler M, Stapleton A, et al
    Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome.
    Oncol Rep. 2010;23:1045-52.
    PubMed     Text format     Related articles    Abstract available


    Prostate

  25. SHANMUGAM R , Kusumanchi P, Cheng L, Crooks P, et al
    A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available

  26. LANGEBERG WJ , Tahir SA, Feng Z, Kwon EM, et al
    Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available


    Semin Radiat Oncol

  27. GHILEZAN M , Yan D, Martinez A
    Adaptive Radiation Therapy for Prostate Cancer.
    Semin Radiat Oncol. 2010;20:130-137.
    PubMed     Text format     Related articles    Abstract available


    Urol Int

  28. VAN DER POEL HG , Zevenhoven J, Bergman AM
    Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells.
    Urol Int. 2010;84:212-220.
    PubMed     Text format     Related articles    Abstract available

  29. BUHLER P , Fischer T, Wolf P, Gierschner D, et al
    Comparison of Gene Expression in LNCaP Prostate Cancer Cells after Treatment with Bicalutamide or 5-Alpha-Reductase Inhibitors.
    Urol Int. 2010;84:203-211.
    PubMed     Text format     Related articles    Abstract available

  30. KAWAHARA T , Ishiguro H, Hoshino K, Teranishi JI, et al
    Analysis of NSAID-Activated Gene 1 Expression in Prostate Cancer.
    Urol Int. 2010;84:198-202.
    PubMed     Text format     Related articles    Abstract available

  31. FANNING DM , Fan Y, Fitzpatrick JM, Watson RW, et al
    External Validation of the 2007 and 2001 Partin Tables in Irish Prostate Cancer Patients.
    Urol Int. 2010;84:174-179.
    PubMed     Text format     Related articles    Abstract available

  32. SPAHN M , Weiss C, Bader P, Strobel P, et al
    Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation.
    Urol Int. 2010;84:164-173.
    PubMed     Text format     Related articles    Abstract available

  33. NAYYAR R , Sharma N, Gupta NP
    Prognostic Factors Affecting Progression and Survival in Metastatic Prostate Cancer.
    Urol Int. 2010;84:159-163.
    PubMed     Text format     Related articles    Abstract available

  34. RAVENTOS CX , Orsola A, de Torres I, Cecchini L, et al
    Preoperative Prediction of Pathologically Insignificant Prostate Cancer in Radical Prostatectomy Specimens: The Role of Prostate Volume and the Number of Positive Cores.
    Urol Int. 2010;84:153-158.
    PubMed     Text format     Related articles    Abstract available

  35. PLOUSSARD G , Bastien L, Descazeaud A, Robert G, et al
    Extended Biopsy Protocol Decreases Prostate Cancer Incidence and Risk of Aggressive Disease on Repeated Biopsies Compared with Initial Standard Procedure.
    Urol Int. 2010;84:147-152.
    PubMed     Text format     Related articles    Abstract available

  36. PORTER CR , Suardi N, Capitanio U, Hutterer GC, et al
    A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical Prostatectomy.
    Urol Int. 2010;84:132-140.
    PubMed     Text format     Related articles    Abstract available


    Urology

  37. EVANS C , Dawe R, Carson-Stevens A
    Re: branney et Al.: choosing health, choosing treatment: patient choice after diagnosis of localized prostate cancer (urology 2009;74:968-971).
    Urology. 2010;75:751.
    PubMed     Text format     Related articles   

  38. HALBERT CH , Coyne J, Weathers B, Mahler B, et al
    Racial Differences in Quality of Life Following Prostate Cancer Diagnosis.
    Urology. 2010.
    PubMed     Text format     Related articles    Abstract available

  39. KAMIYA N , Suzuki H, Yano M, Endo T, et al
    Implications of Serum Bone Turnover Markers in Prostate Cancer Patients With Bone Metastasis.
    Urology. 2010.
    PubMed     Text format     Related articles    Abstract available

  40. FALZARANO SM , Zhou M, Hernandez AV, Moussa AS, et al
    Can Saturation Biopsy Predict Prostate Cancer Localization in Radical Prostatectomy Specimens: A Correlative Study and Implications for Focal Therapy.
    Urology. 2010.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: